cefmetazole has been researched along with Bladder Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, R; Asaoka, M; Etani, T; Hori, K; Iida, K; Kawai, N; Kondo, S; Nagai, T; Naiki, T; Nakamura, A; Noda, Y; Nozaki, S; Shimizu, N; Wachino, C; Yanagita, T; Yasui, T | 1 |
1 other study(ies) available for cefmetazole and Bladder Cancer
| Article | Year |
|---|---|
Efficacy of fosfomycin in the prevention of postoperative infection following transurethral resection of bladder tumor during periods of limited cefazolin, cefotiam, and cefmetazole supply.
Topics: Anti-Bacterial Agents; Cefazolin; Cefmetazole; Cefotiam; Fosfomycin; Humans; Urinary Bladder Neoplasms | 2021 |